Capital Markets & Financing
OnCusp Therapeutics Raises Oversubscribed $100 Million Series A Financing to Advance Portfolio of Assets for Cancer Patients
OnCusp Therapeutics, Inc., a biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer patients worldwide, today announced an oversubscribed $100 million Series A financing round.
GSK enters agreement to acquire Aiolos Bio
AIO-001 has potential to expand GSK’s respiratory biologics portfolio to reach a broader portion of asthma patients
Chinese Biopharma Firm WuXi XDC Climbs 36% on Debut in Hong Kong
A Chinese maker of drugs used in cancer treatments surged in Hong Kong after an initial public offering priced at the top of a marketed range, a rare case of strong demand for a listing in the financial hub of the year.
Xi Jinping expected to speak at dinner for US business executives while in San Francisco for Apec
Bloomberg reported on Tuesday that Chinese President Xi Jinping was the headliner.
Axios: “Foreign investment in China goes negative for first time in decades”
by Matt Phillips, Axios Markets “Foreign investment into China turned negative for the first time on record in the third quarter. Why it matters: The outflow of foreign ... Read more
Henlius Deepens Collaboration with Intas to bring Henlius’ Novel anti-PD-1 mAb Serplulimab to Europe and India
Under the terms of the agreement, Henlius will be responsible for clinical development, manufacturing and supply upon launch and will receive a €42 million upfront payment, up to €43 million in regulatory milestones, up to €100 million in commercial sales milestones, and double-digit royalties on net profit from Intas in the licensed territory.
Angita Closes $46 Million Series B Extension
Biotech firm Angitia Biopharmaceuticals has snagged $46 million in a Series B extension round led by Morningside Ventures, according to a company announcement on October 19.
OrbiMed Raises $4.3 Billion Across Private Investment Funds
OrbiMed, a global healthcare investment firm, is pleased to announce it has raised more than $4.3 billion in commitments for its latest private investment funds
Accelerator Life Science Partners Launches Biotechnology Startup Company in Singapore with $16M in Series A Commitments
“ALSP has long been interested in helping to drive biopharma innovation emerging in Singapore,” said Alice Chen, Executive Vice President at ALSP and Automera board member.
